1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) by Country/Region, 2018, 2022 & 2029
2.2 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Segment by Type
2.2.1 Specialty PTA Balloons Catheter
2.2.2 Standard and High-Pressure PTA Balloons Catheter
2.3 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Type
2.3.1 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales Market Share by Type (2018-2023)
2.3.2 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sale Price by Type (2018-2023)
2.4 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Application
2.5.1 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sale Market Share by Application (2018-2023)
2.5.2 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sale Price by Application (2018-2023)
3 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) by Company
3.1 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Breakdown Data by Company
3.1.1 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Annual Sales by Company (2018-2023)
3.1.2 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales Market Share by Company (2018-2023)
3.2 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Annual Revenue by Company (2018-2023)
3.2.1 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue by Company (2018-2023)
3.2.2 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue Market Share by Company (2018-2023)
3.3 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sale Price by Company
3.4 Key Manufacturers Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Location Distribution
3.4.2 Players Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) by Geographic Region
4.1 World Historic Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Size by Geographic Region (2018-2023)
4.1.1 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Size by Country/Region (2018-2023)
4.2.1 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales Growth
4.4 APAC Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales Growth
4.5 Europe Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales Growth
4.6 Middle East & Africa Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales Growth
5 Americas
5.1 Americas Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Country
5.1.1 Americas Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Country (2018-2023)
5.1.2 Americas Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue by Country (2018-2023)
5.2 Americas Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Type
5.3 Americas Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Region
6.1.1 APAC Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Region (2018-2023)
6.1.2 APAC Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue by Region (2018-2023)
6.2 APAC Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Type
6.3 APAC Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) by Country
7.1.1 Europe Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Country (2018-2023)
7.1.2 Europe Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue by Country (2018-2023)
7.2 Europe Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Type
7.3 Europe Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) by Country
8.1.1 Middle East & Africa Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Revenue by Country (2018-2023)
8.2 Middle East & Africa Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Type
8.3 Middle East & Africa Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Percutaneous Transluminal Angioplasty Balloon Catheter (PTA)
10.3 Manufacturing Process Analysis of Percutaneous Transluminal Angioplasty Balloon Catheter (PTA)
10.4 Industry Chain Structure of Percutaneous Transluminal Angioplasty Balloon Catheter (PTA)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Distributors
11.3 Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Customer
12 World Forecast Review for Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) by Geographic Region
12.1 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Market Size Forecast by Region
12.1.1 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Forecast by Region (2024-2029)
12.1.2 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Forecast by Type
12.7 Global Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Forecast by Application
13 Key Players Analysis
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.1.3 Boston Scientific Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.2.3 Medtronic Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 B. Braun
13.3.1 B. Braun Company Information
13.3.2 B. Braun Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.3.3 B. Braun Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 B. Braun Main Business Overview
13.3.5 B. Braun Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.4.3 BD Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Abbott Laboratories
13.5.1 Abbott Laboratories Company Information
13.5.2 Abbott Laboratories Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.5.3 Abbott Laboratories Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Abbott Laboratories Main Business Overview
13.5.5 Abbott Laboratories Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.6.3 Terumo Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
13.7 Asahi Intecc
13.7.1 Asahi Intecc Company Information
13.7.2 Asahi Intecc Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.7.3 Asahi Intecc Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Asahi Intecc Main Business Overview
13.7.5 Asahi Intecc Latest Developments
13.8 Merit Medical Systems
13.8.1 Merit Medical Systems Company Information
13.8.2 Merit Medical Systems Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.8.3 Merit Medical Systems Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Merit Medical Systems Main Business Overview
13.8.5 Merit Medical Systems Latest Developments
13.9 Cardinal Health
13.9.1 Cardinal Health Company Information
13.9.2 Cardinal Health Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.9.3 Cardinal Health Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cardinal Health Main Business Overview
13.9.5 Cardinal Health Latest Developments
13.10 amg International GmbH
13.10.1 amg International GmbH Company Information
13.10.2 amg International GmbH Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.10.3 amg International GmbH Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 amg International GmbH Main Business Overview
13.10.5 amg International GmbH Latest Developments
13.11 Biomerics
13.11.1 Biomerics Company Information
13.11.2 Biomerics Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.11.3 Biomerics Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Biomerics Main Business Overview
13.11.5 Biomerics Latest Developments
13.12 Acotec Scientific Holdings
13.12.1 Acotec Scientific Holdings Company Information
13.12.2 Acotec Scientific Holdings Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Product Portfolios and Specifications
13.12.3 Acotec Scientific Holdings Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Acotec Scientific Holdings Main Business Overview
13.12.5 Acotec Scientific Holdings Latest Developments
14 Research Findings and Conclusion
※参考情報 経皮的血管形成術用バルーンカテーテル(PTA)は、血管の狭窄や閉塞を改善するために用いられる医療機器です。このカテーテルは、血管の内腔に挿入され、狭くなった部分を拡張することによって血流を改善します。PTAは、冠状動脈疾患、末梢動脈疾患、内頚動脈狭窄など、様々な血管病変に対して広く使用されています。また、PTAは、従来の外科手術に比べて低侵襲であり、入院期間が短く、回復が早いといった利点があります。 PTA用バルーンカテーテルは、通常、柔軟なチューブ状の構造を持ち、先端にはバルーンが付いています。このバルーンは、血管内で空気や液体で膨張させることができ、狭窄部を広げる役割を果たします。一般的に、バルーンの材質はポリウレタンやポリエチレンであり、耐圧性や柔軟性が求められます。また、バルーンは、膨張の際に十分な圧力を保持し、狭くなった血管の壁をしっかりと押し広げることができるように設計されています。 PTAバルーンカテーテルの種類には、多くのバリエーションがあります。まず、バルーンのサイズや形状に応じた分類があります。一般的には、直径や長さによって選択されますが、特定の病変に対応するために、特別な形状を持つバルーンもあります。例えば、バルーンの先端がとがったタイプや、特殊な凹凸を持つバルーンなどがあります。これらの特徴により、狭窄の位置や形状によって最適なバルーンを選択することができます。 次に、バルーンの膨張方式による分類もあります。一般的なバルーンカテーテルは、液体やガスで膨張させることができる「バルーン膨張型」です。一方で、「薬剤溶出型バルーン」と呼ばれる新しいタイプのカテーテルも存在します。これは、膨張時に薬剤を局所的に放出することで、術後の再狭窄を防ぐ効果があります。これにより、患者さんの予後が改善されることが期待されています。 PTA用バルーンカテーテルの用途は非常に多岐にわたりますが、主な目的は血流の改善です。特に以下のような病状に対して効果的です。まず、冠状動脈疾患においては、心臓の血流が不足することがあり、これを改善するためにPTAが行われます。末梢動脈疾患では、脚や腕の動脈が狭くなり、血流が制限される場合があり、PTAで血管を拡張することで症状の改善が期待されます。また、内頚動脈狭窄に対してもPTAが用いられ、脳への血流を確保するために重要です。 さらに、PTAは内視鏡的に視覚化しながら行うことができ、技術者はリアルタイムで血管の状態を確認しながら手技を進めることができます。このプロセスには、血管造影などの事前検査が含まれ、狭窄部位の正確な特定と評価が行われます。これにより、手技の安全性と成功率が向上します。 PTAに関連する技術としては、血管造影や血管ステントの挿入が挙げられます。血管造影は、血管の状態を可視化するために造影剤を使用する検査であり、PTAの前後に行われます。一方、血管ステントは、PTAに続いて狭窄部位を保持するために留置されることが多く、再狭窄のリスクを低減します。このように、PTAは他の治療法と組み合わせて行われることが一般的です。 PTAは、その効果的な血管拡張により、多くの患者の生活の質を向上させることに寄与しています。しかし、PTAには限界もあり、すべての患者に対して適用されるわけではありません。特に、血管の石灰化が著しい場合や、広範囲にわたる閉塞がある場合には、他の治療法が考慮されることがあります。また、再狭窄や合併症のリスクも存在するため、適切な候補者の選定や技術者の熟練度が重要です。 最近では、技術の進歩により、より安全かつ効果的なPTAが実施されるようになってきています。例えば、最新のバルーンカテーテルは、より高い圧力で膨張が可能であり、狭窄部位に対してより大きな衝撃力をかけることができるようになっています。また、ハイブリッド治療法として、PTAと内視鏡手術を組み合わせる事例も増えており、治療の選択肢が広がっています。 このように、経皮的血管形成術用バルーンカテーテルは、血管障害に対する重要な治療手段です。その特性や様々な種類、用途について理解することで、患者の治療効果を高めることができるでしょう。今後も、新たな技術や医療機器の開発が期待され、PTAの適用範囲はさらに広がっていくことが予想されます。安全で効果的な治療の実現に向けて、医療従事者の努力が続けられています。 |